¼¼°èÀÇ ¼ÒºñÀÚ Á÷Á¢(DTC) À¯ÀüÀÚ °Ë»ç ½ÃÀå
Direct-to-Consumer (DTC) Genetic Testing
»óǰÄÚµå : 1770163
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 324 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,666,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼ÒºñÀÚ Á÷Á¢(DTC) À¯ÀüÀÚ °Ë»ç ¼¼°è ½ÃÀåÀº 2030³â±îÁö 33¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 15¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼ÒºñÀÚ Á÷Á¢(DTC) À¯ÀüÀÚ °Ë»ç ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 33¾ï ´Þ·¯¿¡ ´ÞÇϰí, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 13.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ´ÜÀÏ¿°±â´ÙÇü(SNP) ĨÀº CAGR 13.6%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á±îÁö 16¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ÿ°Ù ºÐ¼® ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 14.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 1,310¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 16.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼ÒºñÀÚ Á÷Á¢(DTC) À¯ÀüÀÚ °Ë»ç ½ÃÀåÀº 2024³â¿¡ 6¾ï 1,310¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 16.3%·Î 2030³â±îÁö 2¾ï 6,620¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 12.9%¿Í 14.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 14.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¼ÒºñÀÚ Á÷Á¢(DTC) À¯ÀüÀÚ °Ë»ç ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¼ÒºñÀÚ Á÷Á¢ ÀÇ·Ú(DTC) À¯ÀüÀÚ °Ë»ç´Â Áß°³ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¸¦ °ÅÄ¡Áö ¾Ê°í ¼ÒºñÀÚ¿¡°Ô Á÷Á¢ ÆÇ¸ÅµÇ´Â À¯ÀüÀÚ °Ë»ç¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç´Â °³Àο¡°Ô ƯÁ¤ Áúº´ÀÇ À§Çè, Á¶»ó¿¡ ´ëÇÑ Á¤º¸, °Ç°­ ¹× ¿µ¾ç¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÇüÁú µî ´Ù¾çÇÑ ¹®Á¦¿¡ ´ëÇÑ À¯ÀüÀû ¼ÒÀο¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ¼ÒºñÀÚ´Â ÀÌ·¯ÇÑ °Ë»ç¸¦ ¿Â¶óÀÎÀ¸·Î ±¸¸ÅÇϰí ÀϹÝÀûÀ¸·Î Ÿ¾×À̳ª »´ ¸éºÀÀ» Æ÷ÇÔÇÑ Å°Æ®¸¦ »ç¿ëÇÏ¿© DNA »ùÇÃÀ» äÃëÇÏ¿© ºÐ¼®À» À§ÇØ È¸»ç¿¡ ´Ù½Ã º¸³¾ ¼ö ÀÖ½À´Ï´Ù. °á°ú´Â ÀϹÝÀûÀ¸·Î ¾ÈÀüÇÑ ¿Â¶óÀÎ °èÁ¤À» ÅëÇØ ¾×¼¼½º ÇÒ ¼ö ÀÖÀ¸¸ç, À¯ÀüÇÐÀû °á°ú¿Í ±× ÀáÀçÀû Àǹ̸¦ ¼³¸íÇÏ´Â ÀÚ¼¼ÇÑ º¸°í¼­°¡ Á¦°øµË´Ï´Ù. ÀÌ À¯ÀüÀÚ °Ë»ç ¸ðµ¨Àº À¯ÀüÀÚ Á¤º¸¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½ÃŰ°í ¼ÒºñÀÚ°¡ ÀÚ½ÅÀÇ °Ç°­°ú À¯ÀüÀÚ¿¡ ´ëÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖµµ·Ï ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.

DTC À¯ÀüÀÚ °Ë»ç ½ÃÀåÀº À¯ÀüüÇÐÀÇ ±â¼úÀû Áøº¸¿Í DNA ºÐ¼®ÀÇ ´ëÆøÀûÀÎ ºñ¿ë Àý°¨À¸·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. À¯ÀüÀÚ ½ÃÄö½Ì ±â¼ú°ú µ¥ÀÌÅÍ ºÐ¼®ÀÇ Çõ½ÅÀ¸·Î ±â¾÷µéÀº ÀÌ·¯ÇÑ °Ë»ç¸¦ ¼ÒºñÀÚ Ä£È­ÀûÀÎ °¡°ÝÀ¸·Î Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾úÀ¸¸ç, µ¿½Ã¿¡ ºü¸¥ °á°ú ´äº¯À» º¸ÀåÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. °Ë»ç ¹üÀ§µµ È®´ëµÇ¾î ¼ö¹é °¡Áö Áúº´ÀÇ À§ÇèÀ» Æò°¡ÇÒ ¼ö ÀÖ´Â ÆÐ³Î°ú »ó¼¼ÇÑ °¡°èµµ¸¦ Á¦°øÇÒ ¼ö ÀÖ´Â ÆÐ³ÎÀÌ °¢ ±â¾÷¿¡¼­ Á¦°øµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù¼º ´öºÐ¿¡ ÀÚ½ÅÀÇ À¯ÀüÀÚ ±¸¼º¿¡ °ü½ÉÀÌ ÀÖ´Â ¼ÒºñÀÚµéÀº ÀÚ½ÅÀÇ Á¶»ó¿¡ ´ëÇØ ¾Ë¾Æº¸°í, ƯÁ¤ °Ç°­ »óÅ¿¡ ´ëÇÑ ¼ÒÀÎÀ» ÀÌÇØÇϰí, ƯÁ¤ ¾à¹°¿¡ Àß ¹ÝÀÀÇÏ´ÂÁö, À¯ÀüÀÚ ¸¶Ä¿¿¡ µû¶ó ½Ä´Ü°ú »ýȰ½À°üÀ» Á¶Á¤ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¼ÒºñÀÚÀÇ Àνİú °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ·¯ÇÑ °³ÀÎÈ­µÈ ÀλçÀÌÆ®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀÔ´Ï´Ù.

DTC À¯ÀüÀÚ °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁý´Ï´Ù. °¡Àå Å« ¿øµ¿·ÂÀº °³ÀÎÈ­µÈ °Ç°­ ¹× À£´Ï½º¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½ÉÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. »ç¶÷µéÀÌ ÀÚ½ÅÀÇ °Ç°­¿¡ ´ëÇØ ´õ Àû±ØÀûÀ¸·Î °ü½ÉÀ» °¡Áö°Ô µÇ¸é¼­ ¶óÀÌÇÁ½ºÅ¸ÀÏ ¼±Åðú ÀÇ·áÀû ÀÇ»ç°áÁ¤¿¡ µµ¿òÀ» ÁÙ ¼ö ÀÖ´Â ÀÚ¼¼ÇÑ Á¤º¸¸¦ ¿øÇϰí ÀÖ½À´Ï´Ù. À¯ÀüÀÚ ºÐ¼®ÀÇ Á¤È®µµ¿Í ±íÀ̸¦ ³ôÀÌ´Â ±â¼úÀÇ ¹ßÀüÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, FDA¿Í °°Àº ±â°üÀÇ ¸íÈ®ÇÑ °¡À̵å¶óÀΰú ½ÂÀÎÀº ÀÌ·¯ÇÑ °Ë»çÀÇ Å¸´ç¼º°ú ½Å·Ú¼º¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ½Å·Ú¸¦ ³ôÀ̱â À§ÇØ FDA¿Í °°Àº ±â°üÀÇ ¸íÈ®ÇÑ °¡À̵å¶óÀΰú ½ÂÀÎÀ¸·Î ÀÎÇØ ´õ ¸¹Àº ¼ÒºñÀÚ¸¦ ²ø¾îµéÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÚ½ÅÀÇ °Ç°­Àº ½º½º·Î °ü¸®ÇÑ´Ù´Â °³ÀÎÀÇ ±ÇÇÑ ºÎ¿©¸¦ °­Á¶ÇÏ´Â ¸¶ÄÉÆÃ Àü·«Àº ÀÚ½ÅÀÇ °Ç°­ µ¥ÀÌÅÍ¿Í ¼±ÅñÇÀ» ½º½º·Î ÅëÁ¦ÇϰíÀÚ ÇÏ´Â Çö´ëÀÇ ÇコÄÉ¾î ¼ÒºñÀڵ鿡°Ô Å« °ø°¨À» ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ±× °á°ú, DTC À¯ÀüÀÚ °Ë»ç ½ÃÀåÀº ±â¼ú Çõ½Å°ú ÁøÈ­ÇÏ´Â ¼ÒºñÀÚ Çൿ¿¡ ÈûÀÔ¾î Áö¼ÓÀûÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

°Ë»ç À¯Çü(°¡°è¡¤Ç÷¿¬ °Ë»ç, ¿µ¾çÀ¯ÀüüÇÐ °Ë»ç, ¿¹Ãø °Ë»ç, ij¸®¾î °Ë»ç, ±âŸ °Ë»ç À¯Çü), ±â¼ú(´ÜÀÏ¿°±â´ÙÇü(SNP) Ĩ, Ÿ°Ù ºÐ¼®, ÀüÀå À¯Àüü ½ÃÄö½Ì(WGS)), À¯Åë ä³Î(¿Â¶óÀÎ, ÀϹÝÀǾàǰ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Direct-to-Consumer (DTC) Genetic Testing Market to Reach US$3.3 Billion by 2030

The global market for Direct-to-Consumer (DTC) Genetic Testing estimated at US$1.5 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. Single Nucleotide Polymorphism (SNP) Chips, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Targeted Analysis segment is estimated at 14.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$613.1 Million While China is Forecast to Grow at 16.3% CAGR

The Direct-to-Consumer (DTC) Genetic Testing market in the U.S. is estimated at US$613.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$266.2 Million by the year 2030 trailing a CAGR of 16.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.9% and 14.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.0% CAGR.

Global Direct-to-Consumer (DTC) Genetic Testing Market - Key Trends and Drivers Summarized

Direct-to-Consumer (DTC) genetic testing refers to genetic tests that are marketed directly to consumers without the need for an intermediary healthcare provider. These tests offer individuals insights into their genetic predispositions for a variety of issues, including risks for certain diseases, information about ancestry, and traits affecting wellness and nutrition. Consumers can purchase these tests online, collect a DNA sample using a kit typically involving saliva or a cheek swab, and send it back to the company for analysis. Results are usually accessed via a secure online account, providing detailed reports that explain the genetic findings and their potential implications. This model of genetic testing is aimed at increasing accessibility to genetic information and empowering consumers with knowledge about their health and heritage.

The DTC genetic testing market has expanded rapidly due to technological advances in genomics and a significant reduction in the cost of DNA analysis. Innovations in genetic sequencing technology and data analytics have made it possible for companies to offer these tests at a consumer-friendly price while ensuring a quick turnaround for results. The scope of tests has also broadened, with companies offering panels that can assess risk for hundreds of conditions or provide detailed genealogical histories. This accessibility invites consumers who are curious about their genetic makeup to explore their ancestry, understand their predisposition to certain health conditions, respond better to particular medications, or tailor their diet and lifestyle based on their genetic markers. As consumer awareness and interest grow, the demand for these personalized insights increases, pushing the market forward.

The growth in the DTC genetic testing market is driven by several factors. A key driver is the increasing consumer interest in personalized health and wellness. As people become more proactive about their health, they seek detailed information that could guide their lifestyle choices and medical decisions. Technological advancements that enhance the accuracy and depth of genetic analysis further stimulate market growth. Moreover, the growing trend of preventive healthcare and the potential of genetic testing to contribute to early disease detection and management attract more consumers. Regulatory developments also play a significant role, as clearer guidelines and approvals from bodies like the FDA boost consumer confidence in the validity and reliability of these tests. Additionally, marketing strategies that emphasize the empowerment of individuals to manage their health independently resonate strongly with modern healthcare consumers, who are increasingly inclined to take control of their health data and choices. As a result, the DTC genetic testing market continues to expand, driven by both technological innovation and evolving consumer behavior.

SCOPE OF STUDY:

The report analyzes the Direct-to-Consumer (DTC) Genetic Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing, Other Test Types); Technology (Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis, Whole Genome Sequencing (WGS)); Distribution Channel (Online, Over-the-Counter)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 81 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â